The US Government keeps an online database, at clinicaltrials.gov, of clinical research studies for Mesothelioma cancer, but doesn't review or approve the safety and science of these trials. The website is maintained by the National Library of Medicine (NLM). The links below go to the clinical trial information on clinicaltrials.gov. Talk with your health care professional about possible risks and benefits before joining any studies.
Fri, 9 Feb 2024 00:00:00 EST
Conditions: Advanced Solid Tumor; Mesothelioma, Malignant
Interventions: Drug: SW-682; Drug: Combination Therapy
Sponsors: SpringWorks Therapeutics, Inc.
Not yet recruiting
Tue, 24 Oct 2023 00:00:00 EDT
Conditions: Unresectable Pleural Mesothelioma
Interventions: Drug: Volrustomig; Drug: Pemetrexed; Drug: Carboplatin; Drug: Cisplatin; Drug: Nivolumab; Drug: Ipilimumab
Sponsors: AstraZeneca
Recruiting
Thu, 28 Sep 2023 00:00:00 EDT
Conditions: Malignant Peritoneal Mesothelioma; Peritoneal Mesothelioma; Mesothelioma; Mesothelioma, Malignant; Malignant Mesothelioma
Interventions: Drug: Pemetrexed; Drug: Cisplatin; Drug: Carboplatin
Sponsors: Memorial Sloan Kettering Cancer Center
Recruiting
Thu, 14 Sep 2023 00:00:00 EDT
Conditions: Malignant Pleural Mesothelioma
Interventions: Diagnostic Test: E-Nose testing; Diagnostic Test: Research blood
Sponsors: Memorial Sloan Kettering Cancer Center; UNIVERSITY CAMPUS BIO-MEDICO, ITALY
Recruiting
Wed, 13 Sep 2023 00:00:00 EDT
Conditions: Non Small Cell Lung Cancer; Hepatocellular Carcinoma; Melanoma; Renal Cell Carcinoma; Microsatellite Instability High; Mismatch Repair Deficiency; Mesothelioma; Esophageal Squamous Cell Carcinoma; Squamous Cell Carcinoma of Head and Neck; Urothelial Carcinoma; Cervical Cancer
Interventions: Drug: MT-8421; Drug: Nivolumab
Sponsors: Molecular Templates, Inc.
Recruiting
Mon, 30 Jan 2023 00:00:00 EST
Conditions: Advanced Renal Cell Carcinoma; Advanced Mesothelioma; Advanced Osteosarcoma
Interventions: Drug: CAR.70/IL15-transduced CB-derived NK cells; Drug: Fludarabine phosphate; Drug: Cyclophosphamide
Sponsors: M.D. Anderson Cancer Center
Recruiting
Fri, 16 Dec 2022 00:00:00 EST
Conditions: Malignant Pleural Mesothelioma
Interventions: Radiation: Proton beam therapy
Sponsors: University College, London; Asthma + Lung UK; Mesothelioma UK; University of Sheffield
Recruiting
Thu, 6 Oct 2022 00:00:00 EDT
Conditions: Ovarian Cancer; Cholangiocarcinoma Recurrent; Mesothelioma, Malignant
Interventions: Biological: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR
Sponsors: Verismo Therapeutics
Recruiting
Mon, 19 Sep 2022 00:00:00 EDT
Conditions: Carcinoma, Non-Small-Cell Lung; Cutaneous Melanoma; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Nasopharyngeal Carcinoma; Carcinoma, Thymic; Anal Cancer; Mesothelioma; Esophagogastric Cancer; High Microsatellite Instability Colorectal Carcinoma; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms
Interventions: Drug: KFA115; Drug: pembrolizumab
Sponsors: Novartis Pharmaceuticals
Recruiting
Wed, 14 Sep 2022 00:00:00 EDT
Conditions: Pleural Mesothelioma
Interventions: Device: TTFields
Sponsors: NovoCure GmbH
Recruiting
Menu